retatrutide phase 2 nejm weight loss 48 weeks Trial of for Obesity Retatrutide Week by Week: Weight

If youre considering starting a GLP-1 medication, heres what you need to know before you begin

Most GLP-1 agonists do not require dose adjustment for mild to moderate renal impairment, though specific agents have varying recommendations for severe impairment

Our highly trained and passionate team delivers personalized medical weight loss care through a unique, stackable approach, building patient trust and confidence every step of the way

As anticipated, patient preference is towards GLP-1 RA profiles associated with less frequent dosing, with once-weekly preferred to once-daily, with the latter preferred over twice-daily [123,124,125]